+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Quarterly Research Grant Funding Programme

Cure Parkinson’s

This programme funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief.Our grant funding process has changed! Due to the discontinuation of Grant Tracker, we will be returning to manual processes for research grant funding submissions. Please review all the guidance below for information on how to apply.Our funding remit

For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact us ahead of submission if you are thinking of applying for a clinical trial.

We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be justified and equivalent to academic costs where possible.

How to apply for funding

Stage 1 applications should be submitted via email to research@cureparkinsons.org.uk.

All stage 1 application documents can be accessed at the bottom of this page, including:

Stage 1 application form
Drug and compound CV (if applicable)
Commercial entity form (if applicable)

Additional documents that can be included at this stage but are not mandatory and should be provided in their own format:

Principal investigator/Co-investigator CVs
Budget breakdown
Any supplementary documents to support the application (for example, further preliminary data, clinical trial protocol, publications)

Following Research Committee review of stage 1 applications, stage 2 applications will be invited on an individual basis and provided with the necessary documents via email.

The application process

If the proposed project falls within Cure Parkinson’s scope for funding, it will be considered by our independent research committee, which meets on a quarterly basis.

At each meeting, the committee will discuss stage 1 Applications and decide whether they are within remit and should be evaluated further. If they decide that an application should be considered for funding, the applicant will be invited to submit a full application (stage 2) which will subsequently be sent for externally peer review. The feedback from the expert reviews will be discussed at the next quarterly Research Committee meeting, and a recommendation on whether to fund the project will be made for the Cure Parkinson’s trustees to consider. For successful applicants, the process takes approximately three months but can take longer, particularly for clinical trials where an iterative approach may apply.

All successful and unsuccessful applicants will be notified by the chair of the Research Committee and/or a suitable Cure Parkinson’s representative.

AI based application success predictor

While Cure Parkinson’s does not publish a detailed numeric scoring rubric, successful projects tend to share these key attributes:

✅ 1. Strong Fit with Cure Parkinson’s Core Mission

Your application must clearly address disease-modifying research — NOT just symptomatic treatment or quality-of-life support without an underlying biological impact.

The goal is projects that slow, stop, or reverse progression and lead toward a cure. Cure Parkinson's

Why this matters: Proposals outside this remit are unlikely to progress beyond initial screening.

✅ 2. Clear Pathway Toward Clinical Translation

For preclinical proposals, reviewers prioritize those with a plausible route into a clinical trial within about five years.

This includes proof-of-concept studies, mechanistic rationale, and evidence the approach could be advanced to human studies. FundsforNGOs

For clinical proposals, clear clinical relevance and appropriate trial design are essential.

✅ 3. Scientific Rigor and Feasibility

Strong proposals clearly outline:

Research questions or hypotheses linked to disease mechanisms

A feasible experimental plan with appropriate methodology

Timeline and milestones that match the funding period and objectives

Clear deliverables tied to measurable outcomes

Rigor and feasibility are key criteria for reviewers and the research committee when advancing applications from Stage 1 to full review. Trialect

✅ 4. Justified Budget & Timeline

Provide a realistic budget breakdown that matches the scope of work (especially for clinical components where costs can escalate) and a timeline that fits the grant period and Cure Parkinson’s expectations (typically 1–3 years). Cure Parkinson's

✅ 5. International & Cross-Sector Eligibility

Cure Parkinson’s accepts applications from around the world and from academic and commercial entities, provided the research fits its mission.

Commercial applicants must complete a commercial entity form and may receive specific scrutiny regarding cost and broader benefit. Trialect

✅ 6. Evidence of Expertise & Capability

Applications that show the research team has:

Relevant prior work/publications

Access to necessary facilities

Strong collaborators or advisory input

are more competitive, especially for larger clinical or translational projects.

✅ 7. Strategic Alignment With iLCT Priorities

If you are targeting research areas prioritized by the International Linked Clinical Trials committee, make sure your application references the iLCT rationale or consult with Cure Parkinson’s research staff for strategic positioning. Cure Parkinson's

✅ 8. Clear Communication and Reviewer-Friendly Narrative

Because Cure Parkinson’s uses:

Internal research committee review

Peer review for full applications
Review clarity and accessibility matter — present a proposal that non-specialist committee members can understand, while satisfying technical reviewers.

🧩 Application Process Notes

Two-stage evaluation

Stage 1 screening form: Short summary of aims, fit, and feasibility.

Full application: For those invited after Stage 1, typically sent for external peer review before committee recommendation.
Timelines are quarterly and decisions usually take ~3 months from submission. Cure Parkinson's

Deadlines are set quarterly, and Cure Parkinson’s encourages early contact with the research team if you’re unsure about fit. Cure Parkinson's

🧠 Summary: Key Success Predictors

Predictor	Why It Matters
Disease-modifying potential	Core focus of the funder — must be central to the project Cure Parkinson's
Translational pathway within ~5 years	Shows potential to reach the clinic FundsforNGOs
Scientific rigor & feasibility	Enables reviewers to trust results Trialect
Clear budget & realistic timeline	Matches scope and increases confidence Cure Parkinson's
Experienced research team	Signals ability to deliver Trialect
Alignment with strategic priorities	Especially for calls like combination therapies

Specialties

Neurosciences

Eligibility Requirements

Principal investigator/Co-investigator CVs

Sponsor Details

Sponsor Institute/Organizations: Cure Parkinson’s

Sponsor Type: Corporate/Non-Profit

Address: 120 New Cavendish Street, London, W1W 6XX

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity